A cost-benefit analysis of the outpatient smoking cessation services in taiwan from a societal viewpoint

Nicotine and Tobacco Research

Volumn 14, Issue 5, 2012, Pages 522-530

  Chen, Pei Ching ^a   Lee, Yue Chune ^a   Tsai, Shih Tzu ^b,c   Lai, Chih Kuan ^d  

^a NATIONAL YANG MING UNIVERSITY   (Taiwan)

^b BUDDHIST TZU CHI GENERAL HOSPITAL   (Taiwan)

^c TZU CHI UNIVERSITY   (Taiwan)

^d TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; COST BENEFIT ANALYSIS; COST CONTROL; FEMALE; HEALTH CARE COST; HUMAN; LIFE EXPECTANCY; MAJOR CLINICAL STUDY; MALE; OUTPATIENT; PRIORITY JOURNAL; PRODUCTIVITY; RELAPSE; SENSITIVITY ANALYSIS; SMOKING CESSATION; SMOKING CESSATION PROGRAM; TAIWAN;

EID: 84860524930     PISSN: 14622203     EISSN: 1469994X     Source Type: Journal    
DOI: 10.1093/ntr/ntr241     Document Type: Article

References (31)

1. Aday, L. A. (1996). Designing and conducting health surveys: A comprehensive guide (2nd ed.). San Francisco, CA: Jossey-Bass.
2. Bureau of Health Promotion, Department of Health, Executive Yuan, Taiwan. (2009). Taiwan Tobacco Control Annual Report. Taipei, Taiwan: Author.
3. Bureau of National Health Insurance. (2008). 2007 National Health Insurance actuarial premium rates report. Taipei, Taiwan: Department of Health, Executive Yuan, Taiwan.
4. Cahill, K., Stead, L. F., & Lancaster, T. (2008). Nicotine receptor partial agonists for smoking cessation. Cochrane Database of Systematic Reviews, (3), CD006103. doi:10.1002/14651858.CD006103.pub3
5. Chang, F. C., Hu, T. W., Lin, M., Yu, P. T., & Chao, K. Y. (2008). Effects of financing smoking cessation outpatient services in Taiwan. Tobacco Control, 17, 183-189. doi:10.1136/tc.2007.021907
6. Chang, F. C., Hu, T. W., Lo, S. Y., Yu, P. T., Chao, K. Y., & Hsiao, M. L. (2010). Quit smoking advice from health professionals in Taiwan: The role of funding policy and smoker socioeconomic status. Tobacco Control, 19, 44-49. doi:10.1136/tc.2009.031435
7. Chung, C. W., Wang, J. D., Yu, C. F., & Yang, M. C. (2007). Lifetime medical expenditure and life expectancy lost attributable to smoking through major smoking related diseases in Taiwan. Tobacco Control, 16, 394-399. doi:10.1136/tc.2006.018986
8. Department of Statistics. (2007). Abridged life table in Taiwan 2007. Retrieved from http://www.moi.gov.tw/stat/english/life.asp
9. Doll, R., Peto, R., Boreham, J., & Sutherland, I. (2004). Mortality in relation to smoking: 50 years' observations on male British doctors. British Medical Journal, 328, 1519. doi:10.1136/bmj.38142.554479.AE
10. Drummond, M. F., Sculpher, M. J., Torrance, G. W., O'Brien, B. J., & Stoddart, G. L. (2005). Methods for the economic evaluation of health care programmes (3rd ed.). NY: Oxford University Press.
11. Fiscella, K., & Franks, P. (1996). Cost-effectiveness of the transdermal nicotine patch as an adjunct to physicians' smoking cessation counseling. Journal of the American Medical Association, 275, 1247-1251. doi:10.1001/jama.1996.03530400035035
12. Fishman, P. A., Khan, Z. M., Thompson, E. E., & Curry, S. J. (2003). Health care costs among smokers, former smokers, and never smokers in an HMO. Health Services Research, 38, 733-749. doi:10.1111/1475-6773.00142
13. Hawkins, J., Hollingworth, W., & Campbell, R. (2010). Long-term smoking relapse: A study using the british household panel survey. Nicotine & Tobacco Research, 12, 1228-1235. doi:10.1093/ntr/ntq175
14. Hsueh, K. C., Chen, C. Y., Yang, Y. H., & Huang, C. L. (2010). Smoking cessation program in outpatient clinics of Family Medicine Department in Taiwan: A longitudinal evaluation. Evaluation & the Health Professions, 33, 12-25. doi:10.1177/0163278709356185
15. Hughes, J. R., Stead, L. F., & Lancaster, T. (2007). Antidepressants for smoking cessation. Cochrane Database of Systematic Reviews, (1), 1-119. doi:10.1002/14651858.CD000031.pub3
16. Jackson, K. C., II, Nahoopii, R., Said, Q., Dirani, R., & Brixner, D. (2007). An employer-based cost-benefit analysis of a novel pharmacotherapy agent for smoking cessation. Journal of Occupational and Environmental Medicine, 49, 453-460. doi:10.1097/JOM.0b013e3180459ff2
17. Javitz, H. S., Swan, G. E., Zbikowski, S. M., Curry, S. J., McAfee, T. A., Decker, D. L., et al. (2004). Cost-effectiveness of different combinations of bupropion SR dose and behavioral treatment for smoking cessation: A societal perspective. American Journal of Managed Care, 10, 217-226.
18. Kaper, J., Wagena, E. J., Severens, J. L., & Van Schayck, C. P. (2005). Healthcare financing systems for increasing the use of tobacco dependence treatment. Cochrane Database of Systematic Reviews, (1), 1-38. doi:10.1002/14651858.CD004305.pub2
19. Kaper, J., Wagena, E. J., van Schayck, C. P., & Severens, J. L. (2006). Encouraging smokers to quit: The cost effectiveness of reimbursing the costs of smoking cessation treatment. Pharmacoeconomics, 24, 453-464. doi:10.2165/00019053-200624050-00004
20. Koopmanschap, M. A., Rutten, F. F., van Ineveld, B. M., & van Roijen, L. (1995). The friction cost method for measuring indirect costs of disease. Journal of Health Economics, 14, 171-189. doi. 10.1016/0167-6296(94)00044-5
21. Koopmanschap, M. A., & van Ineveld, B. M. (1992). Towards a new approach for estimating indirect costs of disease. Social Science & Medicine, 34, 1005-1010. doi:10.1016/0277-9536(92)90131-9
22. Lancaster, T., & Stead, L. F. (2005). Individual behavioural counselling for smoking cessation. Cochrane Database of Systematic Reviews, (2), CD001292. doi:10.1002/14651858.CD001292.pub2
23. Nielsen, K., & Fiore, M. C. (2000). Cost-benefit analysis of sustained-release bupropion, nicotine patch, or both for smoking cessation. Preventive Medicine, 30, 209-216. doi:10.1006/pmed.1999.0627
24. Roski, J., Jeddeloh, R., An, L., Lando, H., Hannan, P., Hall, C., et al. (2003). The impact of financial incentives and a patient registry on preventive care quality: Increasing provider adherence to evidence-based smoking cessation practice guidelines. Preventive Medicine, 36, 291-299. doi:10.1016/S0091-7435(02)00052-X
25. Shearer, J., & Shanahan, M. (2006). Cost effectiveness analysis of smoking cessation interventions. Australian and New Zealand Journal of Public Health, 30, 428-434. doi:10.1111/j.1467-842X.2006.tb00458.x
26. Stead, L. F., Perera, R., Bullen, C., Mant, D., & Lancaster, T. (2008). Nicotine replacement therapy for smoking cessation. Cochrane Database of Systematic Reviews, (1), 1-160. doi:10.1002/14651858.CD000146.pub3
27. van den Hout, W. B. (2010). The value of productivity: Human-capital versus friction-cost method. Annals of the Rheumatic Diseases, 69(Suppl. 1), i89-i91. doi:10.1136/ard.2009.117150
28. Warner, K. E., Hodgson, T. A., & Carroll, C. E. (1999). Medical costs of smoking in the United States: Estimates, their validity, and their implications. Tobacco Control, 8, 290-300. doi:10.1136/tc.8.3.290
29. Weiss, S. J., Jurs, S., Lesage, J. P., & Iverson, D. C. (1984). A cost-benefit analysis of a smoking cessation program. Evaluation and Program Planning, 7, 337-346.
30. Wen, C. P., Tsai, S. P., Chen, C. J., & Cheng, T. Y. (2004). The mortality risks of smokers in Taiwan: Part I: Cause-specific mortality. Preventive Medicine, 39, 528-535. doi:10.1016/j.ypmed.2004.02.010
31. Yang, M. C., Fann, C. Y., Wen, C. P., & Cheng, T. Y. (2005). Smoking attributable medical expenditures, years of potential life lost, and the cost of premature death in Taiwan. Tobacco Control, 14(Suppl. 1), i62-i70. doi:10.1136/tc.2004.007963